Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis

NCT01408082 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

917

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharitis

Interventions

DRUG: ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined)
DRUG: Azasite
DRUG: Dexamethasone
OTHER: Vehicle

Sponsor

Sun Pharmaceutical Industries Limited